Coagulation dysfunction events associated with novel tetracycline-class drugs: a disproportionality and Bayesian analysis based on the FAERS database. [PDF]
Li H +5 more
europepmc +1 more source
Preventing overfilling of blood bags to reduce clot formation and improve donor safety
Abstract Background and Objectives Overfilling of blood bags is common in low‐resource settings, causing clot formation, donor and recipient risks and blood wastage. This study assessed overfilling prevalence and evaluated a low‐cost intervention to mitigate it.
Kabiru M. Sulaiman +6 more
wiley +1 more source
Coagulation activation in anorexia nervosa: increased tissue factor and prothrombin fragment 1+2. [PDF]
Egedal JM +4 more
europepmc +1 more source
Abstract Objective To describe the perioperative and long‐term outcomes of dogs with massive hepatocellular carcinoma (HCC) in the right hepatic division causing compression or involvement of the caudal vena cava (CVC) treated with right divisional hepatectomy using temporary caval occlusion (TCO). Study design Retrospective case series.
Kumiko Ishigaki +6 more
wiley +1 more source
Standardization of coagulometric tests in griffon vultures (<i>Gyps fulvus</i>): PT, aPTT and factor V reference values. [PDF]
De Pablo-Moreno JA +7 more
europepmc +1 more source
Risk of intracranial hemorrhage in critically ill ACLF patients: a retrospective single center cohort study. [PDF]
Dibos M +6 more
europepmc +1 more source
The need for dried plasma—Still a national issue: Where are we and recommendations
Transfusion, EarlyView.
Anthony E. Pusateri +24 more
wiley +1 more source
ABSTRACT Objectives Endoscopic injection sclerotherapy with ligation (EISL) is a combined endoscopic treatment that involves endoscopic injection sclerotherapy (EIS) and endoscopic variceal ligation. This study aimed to compare the efficacy of conventional EIS and EISL in treating esophageal varices and the usefulness of EISL.
Keita Maki +6 more
wiley +1 more source
Development and Validation of the TCAP Nomogram for Predicting Hepatotoxicity Risk in Hepatocellular Carcinoma Patients Receiving TACE Combined with Systemic Therapy. [PDF]
Ma S, Shi C, Chen J, Song J, Li J.
europepmc +1 more source

